85 related articles for article (PubMed ID: 1822150)
1. [Oral infection by Y. enterocolitica 0:8. Studies of immunization in a murine model].
Frades MC; Díaz R
Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):608-12. PubMed ID: 1822150
[TBL] [Abstract][Full Text] [Related]
2. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
Vogel U; Autenrieth IB; Berner R; Heesemann J
Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity induced by a Yersinia enterocolitica serovar 0:8 cellular extract.
Di Genaro MS; Escudero ME; Maccioni M; Stefanini de Guzmán AM
Biocell; 1996 Dec; 20(3):235-41. PubMed ID: 9031590
[TBL] [Abstract][Full Text] [Related]
4. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
Singh AK; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
[TBL] [Abstract][Full Text] [Related]
5. Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response.
Di Genaro MS; Cargnelutti DE; Eliçabe JR; Lacoste MG; Valdez S; Gómez N; de Guzmán AM
Rheumatology (Oxford); 2007 Apr; 46(4):590-6. PubMed ID: 17043042
[TBL] [Abstract][Full Text] [Related]
6. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
Rastawicki W
Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
[TBL] [Abstract][Full Text] [Related]
7. A study of immunological cross-reaction between Yersinia enterocolitica 0:9 and Brucella abortus.
Jian H; Chu TP
Dev Biol Stand; 1984; 56():179-83. PubMed ID: 6436093
[TBL] [Abstract][Full Text] [Related]
8. Roles of V antigen in promoting virulence and immunity in yersiniae.
Une T; Brubaker RR
J Immunol; 1984 Oct; 133(4):2226-30. PubMed ID: 6381597
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
[TBL] [Abstract][Full Text] [Related]
10. Characterization of anti-ECA antibodies in rabbit antiserum against rough Yersinia enterocolitica O:3.
Rabsztyn K; Kasperkiewicz K; Duda KA; Li CM; Lukasik M; Radziejewska-Lebrecht J; Skurnik M
Biochemistry (Mosc); 2011 Jul; 76(7):832-9. PubMed ID: 21999545
[TBL] [Abstract][Full Text] [Related]
11. Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages.
Roggenkamp A; Leitritz L; Sing A; Kempf VA; Baus K; Heesemann J
Med Microbiol Immunol; 1999 Dec; 188(3):151-9. PubMed ID: 10776846
[TBL] [Abstract][Full Text] [Related]
12. Roles of V antigen in promoting virulence in Yersiniae.
Une T; Nakajima R; Brubaker RR
Contrib Microbiol Immunol; 1987; 9():179-85. PubMed ID: 3665496
[No Abstract] [Full Text] [Related]
13. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
Chart H; Cheasty T
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of hyperimmune sera to Yersinia enterocolitica].
Vorontsova TA; Khorobrykh VV
Lab Delo; 1989; (9):70. PubMed ID: 2481141
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
16. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against Yersinia enterocolitica common antigen produced by immunization with immunoprecipitates.
Bagger YZ
APMIS; 1991 Nov; 99(11):972-6. PubMed ID: 1958353
[TBL] [Abstract][Full Text] [Related]
18. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
20. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice.
Cai K; Zhang Y; Yang B; Chen S
Vaccine; 2013 Jan; 31(2):334-40. PubMed ID: 23153438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
